Business Description
Marksans Pharma Ltd
ISIN : INE750C01026
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 6.05 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.22 | |||||
Interest Coverage | 76.88 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 13.47 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17.3 | |||||
3-Year EBITDA Growth Rate | 27.3 | |||||
3-Year EPS without NRI Growth Rate | 32.7 | |||||
3-Year FCF Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | 36 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.58 | |||||
9-Day RSI | 60.05 | |||||
14-Day RSI | 59.81 | |||||
6-1 Month Momentum % | 37.43 | |||||
12-1 Month Momentum % | 75.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.12 | |||||
Quick Ratio | 3.53 | |||||
Cash Ratio | 2.02 | |||||
Days Inventory | 173.47 | |||||
Days Sales Outstanding | 73.68 | |||||
Days Payable | 67.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.07 | |||||
3-Year Dividend Growth Rate | 71 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 2.09 | |||||
3-Year Average Share Buyback Ratio | -3 | |||||
Shareholder Yield % | 0.14 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.82 | |||||
Operating Margin % | 19.84 | |||||
Net Margin % | 15.11 | |||||
FCF Margin % | 8.75 | |||||
ROE % | 19.49 | |||||
ROA % | 15.42 | |||||
ROIC % | 24.68 | |||||
ROC (Joel Greenblatt) % | 40.25 | |||||
ROCE % | 25.08 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 24.35 | |||||
PE Ratio without NRI | 24.35 | |||||
Shiller PE Ratio | 43.92 | |||||
Price-to-Owner-Earnings | 39.15 | |||||
PEG Ratio | 0.68 | |||||
PS Ratio | 3.69 | |||||
PB Ratio | 4.1 | |||||
Price-to-Tangible-Book | 4.35 | |||||
Price-to-Free-Cash-Flow | 38.91 | |||||
Price-to-Operating-Cash-Flow | 30.12 | |||||
EV-to-EBIT | 16.73 | |||||
EV-to-EBITDA | 14.48 | |||||
EV-to-Revenue | 3.45 | |||||
EV-to-FCF | 39.4 | |||||
Price-to-Median-PS-Value | 2.02 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.97 | |||||
Earnings Yield (Greenblatt) % | 5.98 | |||||
FCF Yield % | 2.36 | |||||
Forward Rate of Return (Yacktman) % | 21.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Marksans Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 21,008.52 | ||
EPS (TTM) (₹) | 7.07 | ||
Beta | 1 | ||
Volatility % | 64.96 | ||
14-Day RSI | 59.81 | ||
14-Day ATR (₹) | 6.939939 | ||
20-Day SMA (₹) | 166.02 | ||
12-1 Month Momentum % | 75.98 | ||
52-Week Range (₹) | 70.55 - 185.5 | ||
Shares Outstanding (Mil) | 453.16 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Marksans Pharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Marksans Pharma Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Marksans Pharma Ltd Frequently Asked Questions
What is Marksans Pharma Ltd(NSE:MARKSANS)'s stock price today?
When is next earnings date of Marksans Pharma Ltd(NSE:MARKSANS)?
Does Marksans Pharma Ltd(NSE:MARKSANS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |